Papapetropoulos A - Search Results

1

Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA, and protein levels by cAMP-elevating agents.

Papapetropoulos A, Marczin N, Mora G, Milici A, Murad F, Catravas JD. Papapetropoulos A, et al. Hypertension. 1995 Oct;26(4):696-704. doi: 10.1161/01.hyp.26.4.696. Hypertension. 1995. PMID: 7558233

2

Smooth muscle cell responsiveness to nitrovasodilators in hypertensive and normotensive rats.

Papapetropoulos A, Marczin N, Snead MD, Cheng C, Milici A, Catravas JD. Papapetropoulos A, et al. Hypertension. 1994 Apr;23(4):476-84. doi: 10.1161/01.hyp.23.4.476. Hypertension. 1994. PMID: 7511569

3

Prevention of nitric oxide synthase induction in vascular smooth muscle cells by microtubule depolymerizing agents.

Marczin N, Papapetropoulos A, Jilling T, Catravas JD. Marczin N, et al. Among authors: papapetropoulos a. Br J Pharmacol. 1993 Jul;109(3):603-5. doi: 10.1111/j.1476-5381.1993.tb13613.x. Br J Pharmacol. 1993. PMID: 7689397 Free PMC article.

4

Tyrosine kinase inhibitors suppress endotoxin- and IL-1 beta-induced NO synthesis in aortic smooth muscle cells.

Marczin N, Papapetropoulos A, Catravas JD. Marczin N, et al. Among authors: papapetropoulos a. Am J Physiol. 1993 Sep;265(3 Pt 2):H1014-8. doi: 10.1152/ajpheart.1993.265.3.H1014. Am J Physiol. 1993. PMID: 8214107

5

cGMP accumulation and gene expression of soluble guanylate cyclase in human vascular tissue.

Papapetropoulos A, Cziraki A, Rubin JW, Stone CD, Catravas JD. Papapetropoulos A, et al. J Cell Physiol. 1996 May;167(2):213-21. doi: 10.1002/(SICI)1097-4652(199605)167:2<213::AID-JCP4>3.0.CO;2-S. J Cell Physiol. 1996. PMID: 8613461

6

Cytoskeleton-dependent activation of the inducible nitric oxide synthase in cultured aortic smooth muscle cells.

Marczin N, Jilling T, Papapetropoulos A, Go C, Catravas JD. Marczin N, et al. Among authors: papapetropoulos a. Br J Pharmacol. 1996 Jul;118(5):1085-94. doi: 10.1111/j.1476-5381.1996.tb15510.x. Br J Pharmacol. 1996. PMID: 8818330 Free PMC article.

7

Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells.

Papapetropoulos A, Go CY, Murad F, Catravas JD. Papapetropoulos A, et al. Br J Pharmacol. 1996 Jan;117(1):147-55. doi: 10.1111/j.1476-5381.1996.tb15167.x. Br J Pharmacol. 1996. PMID: 8825356 Free PMC article.

8

Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1 beta.

Papapetropoulos A, Abou-Mohamed G, Marczin N, Murad F, Caldwell RW, Catravas JD. Papapetropoulos A, et al. Br J Pharmacol. 1996 Jul;118(6):1359-66. doi: 10.1111/j.1476-5381.1996.tb15545.x. Br J Pharmacol. 1996. PMID: 8832057 Free PMC article.

9

Induction of nitric oxide synthase by protein synthesis inhibition in aortic smooth muscle cells.

Marczin N, Go CY, Papapetropoulos A, Catravas JD. Marczin N, et al. Among authors: papapetropoulos a. Br J Pharmacol. 1998 Mar;123(5):1000-8. doi: 10.1038/sj.bjp.0701687. Br J Pharmacol. 1998. PMID: 9535031 Free PMC article.

10

Cross-tolerance between endogenous nitric oxide and exogenous nitric oxide donors.

Papapetropoulos A, Marczin N, Catravas JD. Papapetropoulos A, et al. Eur J Pharmacol. 1998 Mar 5;344(2-3):313-21. doi: 10.1016/s0014-2999(97)01595-1. Eur J Pharmacol. 1998. PMID: 9600668

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters